BioSpace News Archive

Three years ago this week, Abiomed’s Impella heart pump received its FDA PMA approval for AMI cardiogenic shock.

Spheryx introduces xSight with live demonstrations at a leading international conference on protein-based therapeutics. The technology meets a critical industry need for the detection and characterization of protein aggregates, a safety hazard in biologic pharmaceuticals.

Neptune Wellness Solutions Inc. is pleased to announce its participation at the GMP Securities Cannabis Conference to be held in Toronto April 16, 2019.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is proud to join the LGBTQ community in celebrating the 2019 LGBTQ Pride season through its participation in 24 Pride events across the country—in many locations, touring with its “Our Champions” Pride bus.

Daiichi Sankyo Company, Limited announced that the U.S. Food and Drug Administration has extended the review period for the New Drug Application of quizartinib, an investigational FLT3 inhibitor, currently under Priority Review for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia.

The Annual NaBITA Conference is the leading conference in the field of higher education threat assessment and behavioral intervention.

The North Carolina Mesothelioma Victims Center says, “We are now urging a person with mesothelioma or asbestos exposure lung cancer anywhere in North Carolina or their family to call us anytime at 800-714-0303.

Puma Biotechnology, Inc., a biopharmaceutical company, has expanded two additional cohorts from the Phase II SUMMIT clinical trial investigating its lead drug candidate neratinib in patients with solid tumors who have an activating EGFR or HER2 mutation.

Shamrock Farms Helps People Make the Most of Everyday with New Energy Boosting Protein Beverage

Medical Marijuana, Inc. , the first-ever publicly traded cannabis company in the United States, announced that the company had its the largest-ever sales month in its history in March 2019.